AstraZeneca Halts COVID Vaccine Trial After ‘Unexplained Illness’


AstraZeneca (AZN.L) has paused human trials of a COVID-19 vaccine developed in partnership with the University of Oxford.

StatNews, a specialist medical website in the US, first reported on Tuesday evening that AstraZeneca had paused a large Phase Three trial of AZD1222, an experimental vaccine previously known as ChAdOx1 nCoV-19.

A spokesperson for AstraZeneca confirmed to Yahoo Finance UK the trial had been halted after the discovery of an “unexplained illness” in one patient.

A spokesperson said the pause was voluntary and part of a “standard review process.” An independent committee will now review the incident and decide whether to resume.

UK Yahoo

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s